NCT00186836
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
- Locations
-
- St. Joseph's Healthcare Hamilton, Ontario, Canada
Clinical trial condition
Hepatitis B
Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.
458 public trials
28 recruiting studies
Hepatitis B trial results
NCT00219453
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT00291967
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
- Locations
-
- Manila, Philippines
NCT00383383
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Clinical Trials Call Center Hradec, Králové, Czechia
- GSK Clinical Trials Call Center Kuala Lumpur, Malaysia
- GSK Clinical Trials Call Center Málaga, Spain
NCT00380614
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- G.B. Pant Hospital New Delhi, National Capital Territory of Delhi, India
Completed
Qidong Hepatitis B Intervention Study
NCT00222664
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +17 more
- Locations
-
- Qidong Liver Cancer Institute Qidong, Jiangsu, China
- Cancer Institute, Chinese Academy of Medical Sciences Beijing, China
- Clinical Trial Service Unit and Epidemiological Studies Unit Oxford, United Kingdom
Active, Not Recruiting
Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)
NCT06497504
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
- Locations
-
- GSK Investigational Site Bakersfield, California, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site West Palm Beach, Florida, United States
Active, Not Recruiting
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
NCT06537414
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
- Locations
-
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site San Jose, California, United States
- GSK Investigational Site Minneapolis, Minnesota, United States
- GSK Investigational Site New York, United States
Active, Not Recruiting
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
NCT04954859
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site Sacramento, California, United States
- GSK Investigational Site San Jose, California, United States
- GSK Investigational Site Colorado Springs, Colorado, United States
- GSK Investigational Site Boston, Massachusetts, United States
Active, Not Recruiting
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
NCT07168356
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +15 more
- Locations
-
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site Tampa, Florida, United States
- GSK Investigational Site San Antonio, Texas, United States